Pages that link to "Q24631549"
Jump to navigation
Jump to search
The following pages link to Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector (Q24631549):
Displaying 50 items.
- Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide‐induced mitotically arrested cells (Q24337180) (← links)
- From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia (Q24605527) (← links)
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway (Q24623800) (← links)
- Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists (Q24632161) (← links)
- Carcinogenic Effects of “Whole-Life” Exposure to Inorganic Arsenic in CD1 Mice (Q24707869) (← links)
- The hedgehog pathway in triple-negative breast cancer (Q26740373) (← links)
- Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors (Q26764892) (← links)
- Hedgehog Cholesterolysis: Specialized Gatekeeper to Oncogenic Signaling (Q26782305) (← links)
- The Role of Hedgehog Signaling in Tumor Induced Bone Disease (Q26783615) (← links)
- Hedgehog Signaling in Malignant Pleural Mesothelioma (Q26799894) (← links)
- Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy (Q26865136) (← links)
- Basal cell carcinoma - molecular biology and potential new therapies (Q27006913) (← links)
- Darinaparsin is a multivalent chemotherapeutic which induces incomplete stress response with disruption of microtubules and Shh signaling (Q27312382) (← links)
- FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer (Q28269779) (← links)
- Survival regulation of leukemia stem cells (Q28271278) (← links)
- Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation (Q28534552) (← links)
- TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response (Q28548386) (← links)
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance (Q28833786) (← links)
- VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells (Q30514653) (← links)
- Management of pediatric and adult patients with medulloblastoma (Q30847947) (← links)
- The role of GLI1 for 5-Fu resistance in colorectal cancer (Q33560768) (← links)
- Advanced treatment for basal cell carcinomas (Q33790684) (← links)
- Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells (Q33823359) (← links)
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition (Q34426872) (← links)
- Arsenic: a potentially useful poison for Hedgehog-driven cancers (Q34429067) (← links)
- Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression (Q34978872) (← links)
- Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. (Q34981146) (← links)
- Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia (Q35018971) (← links)
- The hedgehog/Gli signaling paradigm in prostate cancer (Q35109835) (← links)
- Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002. (Q35531884) (← links)
- Neuropilins are positive regulators of Hedgehog signal transduction. (Q35569650) (← links)
- Active site targeting of hedgehog precursor protein with phenylarsine oxide. (Q35601660) (← links)
- Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia. (Q35602348) (← links)
- Hedgehog pathway as a drug target: Smoothened inhibitors in development (Q35885181) (← links)
- Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update (Q35904534) (← links)
- Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened (Q35987233) (← links)
- Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis (Q36040432) (← links)
- Identification and functional characterization of novel transcriptional enhancers involved in regulating human GLI3 expression during early development. (Q36173741) (← links)
- Molecular pathways: the hedgehog signaling pathway in cancer (Q36243790) (← links)
- Hedgehog pathway inhibition and the race against tumor evolution (Q36317210) (← links)
- Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling. (Q36408686) (← links)
- Arsenic Attenuates GLI Signaling, Increasing or Decreasing its Transcriptional Program in a Context-Dependent Manner. (Q36502959) (← links)
- Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein (Q36579412) (← links)
- Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma. (Q36728942) (← links)
- Sonic Hedgehog promotes proliferation of Notch-dependent monociliated choroid plexus tumour cells. (Q36746500) (← links)
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. (Q36803750) (← links)
- From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network (Q36819689) (← links)
- A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood (Q36866043) (← links)
- Targeting sonic hedgehog signaling by compounds and derivatives from natural products (Q36950021) (← links)
- The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy (Q36902958) (← links)